172 related articles for article (PubMed ID: 20430637)
1. Efficient preparation of (99m)Tc(III) '4+1' mixed-ligand complexes for peptide labeling with high specific activity.
Kunstler JU; Seidel G; Pietzsch HJ
Appl Radiat Isot; 2010 Sep; 68(9):1728-33. PubMed ID: 20430637
[TBL] [Abstract][Full Text] [Related]
2. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
3. Novel 99mTc '4 + 1' peptide conjugates: tuning the biodistribution by variation of coligands.
Kunstler JU; Seidel G; Bergmann R; Gniazdowska E; Walther M; Schiller E; Decristoforo C; Stephan H; Haubner R; Steinbach J; Pietzsch HJ
Eur J Med Chem; 2010 Sep; 45(9):3645-55. PubMed ID: 20570022
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.
Bolzati C; Benini E; Cazzola E; Jung C; Tisato F; Refosco F; Pietzsch HJ; Spies H; Uccelli L; Duatti A
Bioconjug Chem; 2004; 15(3):628-37. PubMed ID: 15149191
[TBL] [Abstract][Full Text] [Related]
5. Impact of functionalized coligands on the pharmacokinetics of 99mTcIII '4+1' mixed-ligand complexes conjugated to bombesin.
Kunstler JU; Bergmann R; Gniazdowska E; Koźmiński P; Walther M; Pietzsch HJ
J Inorg Biochem; 2011 Nov; 105(11):1383-90. PubMed ID: 21946438
[TBL] [Abstract][Full Text] [Related]
6. A solid-phase labeling strategy for the preparation of technetium and rhenium bifunctional chelate complexes and associated peptide conjugates.
Riddoch RW; Schaffer P; Valliant JF
Bioconjug Chem; 2006; 17(1):226-35. PubMed ID: 16417273
[TBL] [Abstract][Full Text] [Related]
7. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
[TBL] [Abstract][Full Text] [Related]
8. Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P.
Smilkov K; Janevik E; Guerrini R; Pasquali M; Boschi A; Uccelli L; Di Domenico G; Duatti A
Appl Radiat Isot; 2014 Sep; 92():25-31. PubMed ID: 24973465
[TBL] [Abstract][Full Text] [Related]
9. N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.
Banerjee SR; Maresca KP; Stephenson KA; Valliant JF; Babich JW; Graham WA; Barzana M; Dong Q; Fischman AJ; Zubieta J
Bioconjug Chem; 2005; 16(4):885-902. PubMed ID: 16029030
[TBL] [Abstract][Full Text] [Related]
10. 2,3,5,6-Tetrafluorophenyl N-(S-benzoylthioacetyl)glycylglycyl- p-aminobenzoate, a heterobifunctional (99m)Tc ligand for precomplexed antibody labeling.
Calderon Sanchez O; Mohammed A; Mier W; Graham K; Schuhmacher J; Arndt SO; Haberkorn U; Mocelo R; Eisenhut M
Bioconjug Chem; 2003; 14(6):1209-13. PubMed ID: 14624637
[TBL] [Abstract][Full Text] [Related]
11. A new strategy for the preparation of peptide-targeted technetium and rhenium radiopharmaceuticals. The automated solid-phase synthesis, characterization, labeling, and screening of a peptide-ligand library targeted at the formyl peptide receptor.
Stephenson KA; Banerjee SR; Sogbein OO; Levadala MK; McFarlane N; Boreham DR; Maresca KP; Babich JW; Zubieta J; Valliant JF
Bioconjug Chem; 2005; 16(5):1189-95. PubMed ID: 16173797
[TBL] [Abstract][Full Text] [Related]
12. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
13. Novel procedures for preparing 99mTc(III) complexes with tetradentate/monodentate coordination of varying lipophilicity and adaptation to 188Re analogues.
Seifert S; Künstler JU; Schiller E; Pietzsch HJ; Pawelke B; Bergmann R; Spies H
Bioconjug Chem; 2004; 15(4):856-63. PubMed ID: 15264874
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of novel oxotechnetium (99Tc and 99mTc) and oxorhenium complexes from the 2,2'-bipyridine (NN)/thiol (S) mixed-ligand system.
Papachristou M; Pirmettis IC; Tsoukalas C; Papagiannopoulou D; Raptopoulou C; Terzis A; Stassinopoulou CI; Chiotellis E; Pelecanou M; Papadopoulos M
Inorg Chem; 2003 Sep; 42(18):5778-84. PubMed ID: 12950229
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of hydrazone formation in HYNIC-peptide conjugate preparation, and its hydrolysis during labeling with (99m)Tc.
Gandomkar M; Najafi R; Shafiei M; Ebrahimi SE
Appl Radiat Isot; 2007 Jul; 65(7):805-8. PubMed ID: 17467277
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571
[TBL] [Abstract][Full Text] [Related]
17. Dramatic effect of the tridentate ligand on the stability of 99mTC "3 + 1" oxo complexes bearing arylpiperazine derivatives.
Fernandes C; Correia JD; Gano L; Santos I; Seifert S; Syhre R; Bergmann R; Spies H
Bioconjug Chem; 2005; 16(3):660-8. PubMed ID: 15898735
[TBL] [Abstract][Full Text] [Related]
18. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals.
Bartholomä M; Valliant J; Maresca KP; Babich J; Zubieta J
Chem Commun (Camb); 2009 Feb; (5):493-512. PubMed ID: 19283279
[TBL] [Abstract][Full Text] [Related]
19. From symmetrical to asymmetrical nitrido phosphino-thiol complexes: a new class of neutral mixed-ligand (99m)Tc compounds as potential brain imaging agents.
Bolzati C; Benini E; Cavazza-Ceccato M; Cazzola E; Malago E; Agostini S; Tisato F; Refosco F; Bandoli G
Bioconjug Chem; 2006; 17(2):419-28. PubMed ID: 16536474
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and preclinical evaluation of rhenium and technetium-99m "4 + 1" mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents.
Kiritsis C; Shegani A; Makrypidi K; Roupa I; Lazopoulos A; Panagiotopoulou A; Triantopoulou S; Paravatou-Petsotas M; Pietzsch HJ; Pelecanou M; Papadopoulos M; Pirmettis I
Bioorg Med Chem; 2022 Nov; 73():117012. PubMed ID: 36155319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
